scispace - formally typeset
A

Annamaria Rapisarda

Researcher at Science Applications International Corporation

Publications -  35
Citations -  4054

Annamaria Rapisarda is an academic researcher from Science Applications International Corporation. The author has contributed to research in topics: Angiogenesis & Cancer. The author has an hindex of 23, co-authored 31 publications receiving 3760 citations.

Papers
More filters
Journal ArticleDOI

Regulation of the chemokine receptor CXCR4 by hypoxia.

TL;DR: It is described that oxygen availability is a determinant parameter in the setting of chemotactic responsiveness to stromal-derived factor 1 (CXCL12), and the Hyp–Hyp-inducible factor 1 α–CXCR4 pathway may regulate trafficking in and out of hypoxic tissue microenvironments.
Journal Article

Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway

TL;DR: The luciferase-based high-throughput screen is a feasible tool for the identification of small molecule inhibitors of HIF-1 transcriptional activation and the results suggest that altered Topo-I function may be associated with repression of Hif-1-dependent induction of gene expression.
Journal ArticleDOI

Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.

TL;DR: It is demonstrated that TPT does not affect Hif-1α protein half-life or mRNA accumulation but inhibits its translation, and the existence of a novel pathway connecting Top 1-dependent signaling events and the regulation of HIF-1 α protein expression and function is demonstrated.
Journal ArticleDOI

Development of HIF-1 inhibitors for cancer therapy

TL;DR: The present research attacked the mechanism of action of HIF‐1 inhibitors by targeting the ‘spatially reprograming’ pathway, which results in down-regulation of Hif‐1α transcriptional activity.